Study in Adult Patients With Moderate to Severe Asthma
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Asthma
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: Exploratory, double-blind, randomised, multicenter, 2x2 cross-over studyMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Exploratory, double-blind, randomised, multicenter, 2x2 cross-over studyPrimary Purpose: Other
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Both males and females
Description
Outpatients attending the hospital clinics/study centers will be recruited. Moderate to severe asthma adult subjects will be recruited. A total of 75 subjects will be enrolled. The whole study will last approximately 6 weeks for each subject.
Outpatients attending the hospital clinics/study centers will be recruited. Moderate to severe asthma adult subjects will be recruited. A total of 75 subjects will be enrolled. The whole study will last approximately 6 weeks for each subject.
Tracking Information
- NCT #
- NCT04886999
- Collaborators
- Not Provided
- Investigators
- Study Director: Eva Topole, MD Chiesi Farmaceutici S.p.A.
Get Well Soon